Industry Research Reports

Home > Reports > Medical Care > Global Kidney Cancer Therapeutics Market Research Report 2024

Global Kidney Cancer Therapeutics Market Research Report 2024

Industry: Medical Care

Published Date: 2024-01-17

Pages: 87 Pages

Report ld: 2288399

Request Sample

Customized Report

Description
Table of Contents
Table of Figures
Related Reports
PDF Download

Description
Table of Contents
Table of Figures
Related Reports
PDF Download

Kidney Cancer Therapeutics Market Size(US$)

CAGR 2024-2030

3.8%

Market Size,2030

USD 547

Million

Market Snapshot

Market Size in 2024 (Value)

US$ 437.4 million

Market Forecast in 2030(Value)

US$ 547 million

CAGR

3.8%

Years Considered

2019-2030

Base Year

2024

Forecast Period

2024-2030

Source: Secondary research, interviews with experts, and QYResearch analysis

Kidney cancer is cancer that begins in the kidneys. Your kidneys are two bean-shaped organs, each about the size of your fist. They're located behind your abdominal organs, with one kidney on each side of your spine. In adults, renal cell carcinoma is the most common type of kidney cancer.

The global Kidney Cancer Therapeutics market was valued at US$ 422.9 million in 2023 and is anticipated to reach US$ 547 million by 2030, witnessing a CAGR of 3.8% during the forecast period 2024-2030.

The kidney cancer therapeutics market is evolving rapidly to address the treatment needs of patients diagnosed with kidney cancer, also known as renal cell carcinoma (RCC). This market encompasses a range of therapies, including targeted therapies, immunotherapies, and combination treatments. The increasing incidence of kidney cancer, advancements in understanding its molecular basis, and the emergence of novel treatment options are driving market growth. Targeted therapies that inhibit specific pathways implicated in kidney cancer progression, along with immunotherapies that harness the immune system's response, are gaining prominence. As research continues and personalized treatment approaches gain traction, the kidney cancer therapeutics market is expected to expand, offering new hope for improved outcomes and quality of life for patients with this challenging disease.

This report aims to provide a comprehensive presentation of the global market for Kidney Cancer Therapeutics, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Kidney Cancer Therapeutics.

MARKET SEGMENTATION

By Company

Merck
Novartis
Bristol-Myers Squibb
Pfizer
Roche
Amgen
Aveo Pharmaceuticals
Bayer
Exelixis
Eisai

Consumption by Region

North America
- United States
- Canada
Asia-Pacific
- China
- Japan
- South Korea
- Southeast Asia
- India
- Australia
- Rest of Asia-Pacific
Europe
- Germany
- France
- U.K.
- Italy
- Netherlands
- Nordic Countries
- Rest of Europe
Latin America
- Mexico
- Brazil
- Rest of Latin America
Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
- Rest of MEA

Segment by Type

Surgery
Immunotherapy
Targeted Therapy
Other

Segment by Application

Renal Cell Carcinoma
Renal Pelvis Cancer
Other

biaoTi REPORT SCOPE

The Kidney Cancer Therapeutics market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Kidney Cancer Therapeutics market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Kidney Cancer Therapeutics companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

biaoTi CHAPTER OUTLINE

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Kidney Cancer Therapeutics companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 12: The main points and conclusions of the report.

biaoTi QYRESEARCH'S STRENGTHS

Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:

Market entry risks/opportunities by region

We identify regional market threats and growth prospects to guide your overseas layout.

Product mix optimization based on local practices

We adjust product portfolios in line with local consumption habits.

Competitor tactics in fragmented vs. consolidated markets

We unpack rivals’ operation strategies for scattered and highly concentrated industries.

Full Research Coverage

We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.

19 Years Industry Expertise

We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.

24/7 Fast Report Delivery

Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.

Localized Strategic Analysis

We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.

Market entry risks/opportunities by region

All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.

Market entry risks/opportunities by region

We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.

TABLE OF CONTENTS

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Kidney Cancer Therapeutics Market Size Growth Rate by Type: 2019 VS 2023 VS 2030

1.2.2 Surgery

1.2.3 Immunotherapy

1.2.4 Targeted Therapy

1.2.5 Other

1.3 Market by Application

1.3.1 Global Kidney Cancer Therapeutics Market Growth by Application: 2019 VS 2023 VS 2030

1.3.2 Renal Cell Carcinoma

1.3.3 Renal Pelvis Cancer

1.3.4 Other

1.4 Study Objectives

1.5 Years Considered

1.6 Years Considered

2 Global Growth Trends

2.1 Global Kidney Cancer Therapeutics Market Perspective (2019-2030)

2.2 Kidney Cancer Therapeutics Growth Trends by Region

2.2.1 Global Kidney Cancer Therapeutics Market Size by Region: 2019 VS 2023 VS 2030

2.2.2 Kidney Cancer Therapeutics Historic Market Size by Region (2019-2024)

2.2.3 Kidney Cancer Therapeutics Forecasted Market Size by Region (2025-2030)

2.3 Kidney Cancer Therapeutics Market Dynamics

2.3.1 Kidney Cancer Therapeutics Industry Trends

2.3.2 Kidney Cancer Therapeutics Market Drivers

2.3.3 Kidney Cancer Therapeutics Market Challenges

2.3.4 Kidney Cancer Therapeutics Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Kidney Cancer Therapeutics Players by Revenue

3.1.1 Global Top Kidney Cancer Therapeutics Players by Revenue (2019-2024)

3.1.2 Global Kidney Cancer Therapeutics Revenue Market Share by Players (2019-2024)

3.2 Global Kidney Cancer Therapeutics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Players Covered: Ranking by Kidney Cancer Therapeutics Revenue

3.4 Global Kidney Cancer Therapeutics Market Concentration Ratio

3.4.1 Global Kidney Cancer Therapeutics Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Kidney Cancer Therapeutics Revenue in 2023

3.5 Kidney Cancer Therapeutics Key Players Head office and Area Served

3.6 Key Players Kidney Cancer Therapeutics Product Solution and Service

3.7 Date of Enter into Kidney Cancer Therapeutics Market

3.8 Mergers & Acquisitions, Expansion Plans

4 Kidney Cancer Therapeutics Breakdown Data by Type

4.1 Global Kidney Cancer Therapeutics Historic Market Size by Type (2019-2024)

4.2 Global Kidney Cancer Therapeutics Forecasted Market Size by Type (2025-2030)

5 Kidney Cancer Therapeutics Breakdown Data by Application

5.1 Global Kidney Cancer Therapeutics Historic Market Size by Application (2019-2024)

5.2 Global Kidney Cancer Therapeutics Forecasted Market Size by Application (2025-2030)

6 North America

6.1 North America Kidney Cancer Therapeutics Market Size (2019-2030)

6.2 North America Kidney Cancer Therapeutics Market Growth Rate by Country: 2019 VS 2023 VS 2030

6.3 North America Kidney Cancer Therapeutics Market Size by Country (2019-2024)

6.4 North America Kidney Cancer Therapeutics Market Size by Country (2025-2030)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Kidney Cancer Therapeutics Market Size (2019-2030)

7.2 Europe Kidney Cancer Therapeutics Market Growth Rate by Country: 2019 VS 2023 VS 2030

7.3 Europe Kidney Cancer Therapeutics Market Size by Country (2019-2024)

7.4 Europe Kidney Cancer Therapeutics Market Size by Country (2025-2030)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific Kidney Cancer Therapeutics Market Size (2019-2030)

8.2 Asia-Pacific Kidney Cancer Therapeutics Market Growth Rate by Region: 2019 VS 2023 VS 2030

8.3 Asia-Pacific Kidney Cancer Therapeutics Market Size by Region (2019-2024)

8.4 Asia-Pacific Kidney Cancer Therapeutics Market Size by Region (2025-2030)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9 Latin America

9.1 Latin America Kidney Cancer Therapeutics Market Size (2019-2030)

9.2 Latin America Kidney Cancer Therapeutics Market Growth Rate by Country: 2019 VS 2023 VS 2030

9.3 Latin America Kidney Cancer Therapeutics Market Size by Country (2019-2024)

9.4 Latin America Kidney Cancer Therapeutics Market Size by Country (2025-2030)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Kidney Cancer Therapeutics Market Size (2019-2030)

10.2 Middle East & Africa Kidney Cancer Therapeutics Market Growth Rate by Country: 2019 VS 2023 VS 2030

10.3 Middle East & Africa Kidney Cancer Therapeutics Market Size by Country (2019-2024)

10.4 Middle East & Africa Kidney Cancer Therapeutics Market Size by Country (2025-2030)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 Merck

11.1.1 Merck Company Detail

11.1.2 Merck Business Overview

11.1.3 Merck Kidney Cancer Therapeutics Introduction

11.1.4 Merck Revenue in Kidney Cancer Therapeutics Business (2019-2024)

11.1.5 Merck Recent Development

11.2 Novartis

11.2.1 Novartis Company Detail

11.2.2 Novartis Business Overview

11.2.3 Novartis Kidney Cancer Therapeutics Introduction

11.2.4 Novartis Revenue in Kidney Cancer Therapeutics Business (2019-2024)

11.2.5 Novartis Recent Development

11.3 Bristol-Myers Squibb

11.3.1 Bristol-Myers Squibb Company Detail

11.3.2 Bristol-Myers Squibb Business Overview

11.3.3 Bristol-Myers Squibb Kidney Cancer Therapeutics Introduction

11.3.4 Bristol-Myers Squibb Revenue in Kidney Cancer Therapeutics Business (2019-2024)

11.3.5 Bristol-Myers Squibb Recent Development

11.4 Pfizer

11.4.1 Pfizer Company Detail

11.4.2 Pfizer Business Overview

11.4.3 Pfizer Kidney Cancer Therapeutics Introduction

11.4.4 Pfizer Revenue in Kidney Cancer Therapeutics Business (2019-2024)

11.4.5 Pfizer Recent Development

11.5 Roche

11.5.1 Roche Company Detail

11.5.2 Roche Business Overview

11.5.3 Roche Kidney Cancer Therapeutics Introduction

11.5.4 Roche Revenue in Kidney Cancer Therapeutics Business (2019-2024)

11.5.5 Roche Recent Development

11.6 Amgen

11.6.1 Amgen Company Detail

11.6.2 Amgen Business Overview

11.6.3 Amgen Kidney Cancer Therapeutics Introduction

11.6.4 Amgen Revenue in Kidney Cancer Therapeutics Business (2019-2024)

11.6.5 Amgen Recent Development

11.7 Aveo Pharmaceuticals

11.7.1 Aveo Pharmaceuticals Company Detail

11.7.2 Aveo Pharmaceuticals Business Overview

11.7.3 Aveo Pharmaceuticals Kidney Cancer Therapeutics Introduction

11.7.4 Aveo Pharmaceuticals Revenue in Kidney Cancer Therapeutics Business (2019-2024)

11.7.5 Aveo Pharmaceuticals Recent Development

11.8 Bayer

11.8.1 Bayer Company Detail

11.8.2 Bayer Business Overview

11.8.3 Bayer Kidney Cancer Therapeutics Introduction

11.8.4 Bayer Revenue in Kidney Cancer Therapeutics Business (2019-2024)

11.8.5 Bayer Recent Development

11.9 Exelixis

11.9.1 Exelixis Company Detail

11.9.2 Exelixis Business Overview

11.9.3 Exelixis Kidney Cancer Therapeutics Introduction

11.9.4 Exelixis Revenue in Kidney Cancer Therapeutics Business (2019-2024)

11.9.5 Exelixis Recent Development

11.10 Eisai

11.10.1 Eisai Company Detail

11.10.2 Eisai Business Overview

11.10.3 Eisai Kidney Cancer Therapeutics Introduction

11.10.4 Eisai Revenue in Kidney Cancer Therapeutics Business (2019-2024)

11.10.5 Eisai Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.2 Data Source

13.2 Disclaimer

13.3 Author Details

TABLE OF FIGURES

List of Tables

Table 1. Global Kidney Cancer Therapeutics Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030

Table 2. Key Players of Surgery

Table 3. Key Players of Immunotherapy

Table 4. Key Players of Targeted Therapy

Table 5. Key Players of Other

Table 6. Global Kidney Cancer Therapeutics Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030

Table 7. Global Kidney Cancer Therapeutics Market Size by Region (US$ Million): 2019 VS 2023 VS 2030

Table 8. Global Kidney Cancer Therapeutics Market Size by Region (2019-2024) & (US$ Million)

Table 9. Global Kidney Cancer Therapeutics Market Share by Region (2019-2024)

Table 10. Global Kidney Cancer Therapeutics Forecasted Market Size by Region (2025-2030) & (US$ Million)

Table 11. Global Kidney Cancer Therapeutics Market Share by Region (2025-2030)

Table 12. Kidney Cancer Therapeutics Market Trends

Table 13. Kidney Cancer Therapeutics Market Drivers

Table 14. Kidney Cancer Therapeutics Market Challenges

Table 15. Kidney Cancer Therapeutics Market Restraints

Table 16. Global Kidney Cancer Therapeutics Revenue by Players (2019-2024) & (US$ Million)

Table 17. Global Kidney Cancer Therapeutics Market Share by Players (2019-2024)

Table 18. Global Top Kidney Cancer Therapeutics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Kidney Cancer Therapeutics as of 2023)

Table 19. Ranking of Global Top Kidney Cancer Therapeutics Companies by Revenue (US$ Million) in 2023

Table 20. Global 5 Largest Players Market Share by Kidney Cancer Therapeutics Revenue (CR5 and HHI) & (2019-2024)

Table 21. Key Players Headquarters and Area Served

Table 22. Key Players Kidney Cancer Therapeutics Product Solution and Service

Table 23. Date of Enter into Kidney Cancer Therapeutics Market

Table 24. Mergers & Acquisitions, Expansion Plans

Table 25. Global Kidney Cancer Therapeutics Market Size by Type (2019-2024) & (US$ Million)

Table 26. Global Kidney Cancer Therapeutics Revenue Market Share by Type (2019-2024)

Table 27. Global Kidney Cancer Therapeutics Forecasted Market Size by Type (2025-2030) & (US$ Million)

Table 28. Global Kidney Cancer Therapeutics Revenue Market Share by Type (2025-2030)

Table 29. Global Kidney Cancer Therapeutics Market Size by Application (2019-2024) & (US$ Million)

Table 30. Global Kidney Cancer Therapeutics Revenue Market Share by Application (2019-2024)

Table 31. Global Kidney Cancer Therapeutics Forecasted Market Size by Application (2025-2030) & (US$ Million)

Table 32. Global Kidney Cancer Therapeutics Revenue Market Share by Application (2025-2030)

Table 33. North America Kidney Cancer Therapeutics Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 34. North America Kidney Cancer Therapeutics Market Size by Country (2019-2024) & (US$ Million)

Table 35. North America Kidney Cancer Therapeutics Market Size by Country (2025-2030) & (US$ Million)

Table 36. Europe Kidney Cancer Therapeutics Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 37. Europe Kidney Cancer Therapeutics Market Size by Country (2019-2024) & (US$ Million)

Table 38. Europe Kidney Cancer Therapeutics Market Size by Country (2025-2030) & (US$ Million)

Table 39. Asia-Pacific Kidney Cancer Therapeutics Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030

Table 40. Asia-Pacific Kidney Cancer Therapeutics Market Size by Region (2019-2024) & (US$ Million)

Table 41. Asia-Pacific Kidney Cancer Therapeutics Market Size by Region (2025-2030) & (US$ Million)

Table 42. Latin America Kidney Cancer Therapeutics Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 43. Latin America Kidney Cancer Therapeutics Market Size by Country (2019-2024) & (US$ Million)

Table 44. Latin America Kidney Cancer Therapeutics Market Size by Country (2025-2030) & (US$ Million)

Table 45. Middle East & Africa Kidney Cancer Therapeutics Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 46. Middle East & Africa Kidney Cancer Therapeutics Market Size by Country (2019-2024) & (US$ Million)

Table 47. Middle East & Africa Kidney Cancer Therapeutics Market Size by Country (2025-2030) & (US$ Million)

Table 48. Merck Company Detail

Table 49. Merck Business Overview

Table 50. Merck Kidney Cancer Therapeutics Product

Table 51. Merck Revenue in Kidney Cancer Therapeutics Business (2019-2024) & (US$ Million)

Table 52. Merck Recent Development

Table 53. Novartis Company Detail

Table 54. Novartis Business Overview

Table 55. Novartis Kidney Cancer Therapeutics Product

Table 56. Novartis Revenue in Kidney Cancer Therapeutics Business (2019-2024) & (US$ Million)

Table 57. Novartis Recent Development

Table 58. Bristol-Myers Squibb Company Detail

Table 59. Bristol-Myers Squibb Business Overview

Table 60. Bristol-Myers Squibb Kidney Cancer Therapeutics Product

Table 61. Bristol-Myers Squibb Revenue in Kidney Cancer Therapeutics Business (2019-2024) & (US$ Million)

Table 62. Bristol-Myers Squibb Recent Development

Table 63. Pfizer Company Detail

Table 64. Pfizer Business Overview

Table 65. Pfizer Kidney Cancer Therapeutics Product

Table 66. Pfizer Revenue in Kidney Cancer Therapeutics Business (2019-2024) & (US$ Million)

Table 67. Pfizer Recent Development

Table 68. Roche Company Detail

Table 69. Roche Business Overview

Table 70. Roche Kidney Cancer Therapeutics Product

Table 71. Roche Revenue in Kidney Cancer Therapeutics Business (2019-2024) & (US$ Million)

Table 72. Roche Recent Development

Table 73. Amgen Company Detail

Table 74. Amgen Business Overview

Table 75. Amgen Kidney Cancer Therapeutics Product

Table 76. Amgen Revenue in Kidney Cancer Therapeutics Business (2019-2024) & (US$ Million)

Table 77. Amgen Recent Development

Table 78. Aveo Pharmaceuticals Company Detail

Table 79. Aveo Pharmaceuticals Business Overview

Table 80. Aveo Pharmaceuticals Kidney Cancer Therapeutics Product

Table 81. Aveo Pharmaceuticals Revenue in Kidney Cancer Therapeutics Business (2019-2024) & (US$ Million)

Table 82. Aveo Pharmaceuticals Recent Development

Table 83. Bayer Company Detail

Table 84. Bayer Business Overview

Table 85. Bayer Kidney Cancer Therapeutics Product

Table 86. Bayer Revenue in Kidney Cancer Therapeutics Business (2019-2024) & (US$ Million)

Table 87. Bayer Recent Development

Table 88. Exelixis Company Detail

Table 89. Exelixis Business Overview

Table 90. Exelixis Kidney Cancer Therapeutics Product

Table 91. Exelixis Revenue in Kidney Cancer Therapeutics Business (2019-2024) & (US$ Million)

Table 92. Exelixis Recent Development

Table 93. Eisai Company Detail

Table 94. Eisai Business Overview

Table 95. Eisai Kidney Cancer Therapeutics Product

Table 96. Eisai Revenue in Kidney Cancer Therapeutics Business (2019-2024) & (US$ Million)

Table 97. Eisai Recent Development

Table 98. Research Programs/Design for This Report

Table 99. Key Data Information from Secondary Sources

Table 100. Key Data Information from Primary Sources

List of Figures

Figure 1. Global Kidney Cancer Therapeutics Market Size Comparison by Type (2024-2030) & (US$ Million)

Figure 2. Global Kidney Cancer Therapeutics Market Share by Type: 2023 VS 2030

Figure 3. Surgery Features

Figure 4. Immunotherapy Features

Figure 5. Targeted Therapy Features

Figure 6. Other Features

Figure 7. Global Kidney Cancer Therapeutics Market Size Comparison by Application (2024-2030) & (US$ Million)

Figure 8. Global Kidney Cancer Therapeutics Market Share by Application: 2023 VS 2030

Figure 9. Renal Cell Carcinoma Case Studies

Figure 10. Renal Pelvis Cancer Case Studies

Figure 11. Other Case Studies

Figure 12. Kidney Cancer Therapeutics Report Years Considered

Figure 13. Global Kidney Cancer Therapeutics Market Size (US$ Million), Year-over-Year: 2019-2030

Figure 14. Global Kidney Cancer Therapeutics Market Size, (US$ Million), 2019 VS 2023 VS 2030

Figure 15. Global Kidney Cancer Therapeutics Market Share by Region: 2023 VS 2030

Figure 16. Global Kidney Cancer Therapeutics Market Share by Players in 2023

Figure 17. Global Top Kidney Cancer Therapeutics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Kidney Cancer Therapeutics as of 2023)

Figure 18. The Top 10 and 5 Players Market Share by Kidney Cancer Therapeutics Revenue in 2023

Figure 19. North America Kidney Cancer Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 20. North America Kidney Cancer Therapeutics Market Share by Country (2019-2030)

Figure 21. United States Kidney Cancer Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 22. Canada Kidney Cancer Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 23. Europe Kidney Cancer Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 24. Europe Kidney Cancer Therapeutics Market Share by Country (2019-2030)

Figure 25. Germany Kidney Cancer Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 26. France Kidney Cancer Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 27. U.K. Kidney Cancer Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 28. Italy Kidney Cancer Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 29. Russia Kidney Cancer Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 30. Nordic Countries Kidney Cancer Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 31. Asia-Pacific Kidney Cancer Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 32. Asia-Pacific Kidney Cancer Therapeutics Market Share by Region (2019-2030)

Figure 33. China Kidney Cancer Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 34. Japan Kidney Cancer Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 35. South Korea Kidney Cancer Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 36. Southeast Asia Kidney Cancer Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 37. India Kidney Cancer Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 38. Australia Kidney Cancer Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 39. Latin America Kidney Cancer Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 40. Latin America Kidney Cancer Therapeutics Market Share by Country (2019-2030)

Figure 41. Mexico Kidney Cancer Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 42. Brazil Kidney Cancer Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 43. Middle East & Africa Kidney Cancer Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 44. Middle East & Africa Kidney Cancer Therapeutics Market Share by Country (2019-2030)

Figure 45. Turkey Kidney Cancer Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 46. Saudi Arabia Kidney Cancer Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 47. Merck Revenue Growth Rate in Kidney Cancer Therapeutics Business (2019-2024)

Figure 48. Novartis Revenue Growth Rate in Kidney Cancer Therapeutics Business (2019-2024)

Figure 49. Bristol-Myers Squibb Revenue Growth Rate in Kidney Cancer Therapeutics Business (2019-2024)

Figure 50. Pfizer Revenue Growth Rate in Kidney Cancer Therapeutics Business (2019-2024)

Figure 51. Roche Revenue Growth Rate in Kidney Cancer Therapeutics Business (2019-2024)

Figure 52. Amgen Revenue Growth Rate in Kidney Cancer Therapeutics Business (2019-2024)

Figure 53. Aveo Pharmaceuticals Revenue Growth Rate in Kidney Cancer Therapeutics Business (2019-2024)

Figure 54. Bayer Revenue Growth Rate in Kidney Cancer Therapeutics Business (2019-2024)

Figure 55. Exelixis Revenue Growth Rate in Kidney Cancer Therapeutics Business (2019-2024)

Figure 56. Eisai Revenue Growth Rate in Kidney Cancer Therapeutics Business (2019-2024)

Figure 57. Bottom-up and Top-down Approaches for This Report

Figure 58. Data Triangulation

Figure 59. Key Executives Interviewed

KEY QUESTIONS ADDRESSED BY THE REPORT

What was the global market size of Kidney Cancer Therapeutics in 2024? zhanKai

The global market size of Kidney Cancer Therapeutics in 2024 was 437.4 Million USD.

What was the global market size of Kidney Cancer Therapeutics in 2030? shouQi

Which companies rank high in the global Kidney Cancer Therapeutics market? shouQi

Which region is expected to have the highest market share? shouQi

What is the annual compound growth rate of the global Kidney Cancer Therapeutics market size from 2024 to 2030? shouQi

Related Reports

Kidney Cancer Therapeutics- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Kidney Cancer Therapeutics was estimated to be worth US$ 452 million in 2024 and is forecast to a readjusted size of US$ 585 million by 2031 with a CAGR of 3.8% during the forecast period 2025-2031.
Published Date: 2025-01-13
Pages: 97
USD 3950.00
(Single User License)
Global Kidney Cancer Therapeutics Market Research Report 2025
The global market for Kidney Cancer Therapeutics was valued at US$ 452 million in the year 2024 and is projected to reach a revised size of US$ 585 million by 2031, growing at a CAGR of 3.8% during the forecast period.
Published Date: 2025-01-13
Pages: 78
USD 2900.00
(Single User License)
Global Kidney Cancer Therapeutics Market Insights, Forecast to 2030
Kidney cancer is cancer that begins in the kidneys. Your kidneys are two bean-shaped organs, each about the size of your fist. They're located behind your abdominal organs, with one kidney on each side of your spine. In adults, renal cell carcinoma is the most common type of kidney cancer.
Published Date: 2024-04-15
Pages: 111
USD 4900.00
(Single User License)

Kidney Cancer Therapeutics- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Kidney Cancer Therapeutics was estimated to be worth US$ 452 million in 2024 and is forecast to a readjusted size of US$ 585 million by 2031 with a CAGR of 3.8% during the forecast period 2025-2031.
Published: 2025-01-13
Pages: 97
USD 3950.00 (Single User License)
Global Kidney Cancer Therapeutics Market Research Report 2025
The global market for Kidney Cancer Therapeutics was valued at US$ 452 million in the year 2024 and is projected to reach a revised size of US$ 585 million by 2031, growing at a CAGR of 3.8% during the forecast period.
Published: 2025-01-13
Pages: 78
USD 2900.00 (Single User License)
Global Kidney Cancer Therapeutics Market Insights, Forecast to 2030
Kidney cancer is cancer that begins in the kidneys. Your kidneys are two bean-shaped organs, each about the size of your fist. They're located behind your abdominal organs, with one kidney on each side of your spine. In adults, renal cell carcinoma is the most common type of kidney cancer.
Published: 2024-04-15
Pages: 111
USD 4900.00 (Single User License)